United Therapeutics Corp.

United Therapeutics Corp.

United Therapeutics Corp.

Overview
Date Founded

1996

Headquarters

1040 Spring Street, Silver Spring, MD, 20910, USA

Type of Company

Public

Employees (Worldwide)

860

Industries

Pharmaceuticals
Biotechnology

Company Description

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Contact Data
Trying to get in touch with decision makers at United Therapeutics Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Operating Officer

Chief Financial Officer, Treasurer & Principal Accounting Officer

Executive Vice President, General Counsel & Corporate Secretary

Deputy General Counsel

Chief Information Officer

Professional

Board of Directors

Founder at United Therapeutics Corp.

President at Quinnipiac University

Founding President at Association of Minority Health Professions Schools, Inc.

Executive Manager at Slater Run Vineyards LLC

Co-Founder at Kurzweil Educational Systems, Inc.

Founder at Causey & Co.

Former Private Investor at Société Générale S.A.

Director-Urban Sustainability at Columbia University

Former Vice Dean, Social Impact Initiative at University of Pennsylvania - The Wharton School

Paths to United Therapeutics Corp.
Potential Connections via
Relationship Science
You
United Therapeutics Corp.
Owners & Shareholders
Details Hidden

Palo Alto Investors, LLC (PAI) is a leading private investment firm. We make long-term investments for high-net-worth and institutional investors based on original, deep, fundamental research. We don’t rent stocks. We own them. With approximately $900 million in assets under management, we offer a diversified micro cap fund and healthcare sector funds. Significant partner ownership in all of our Funds serves to align our financial interests with the financial interests of our clients. At PAI our mission is to deliver superior returns to our clients by investing for the long term. At the core of our investment philosophy lies the belief that intensive, original research is required to discover and evaluate inefficiently priced equities. We generally focus our investments in micro cap and small cap U.S. equities, which are not closely followed by Wall Street sell-side research firms. We target overlooked, misunderstood and undervalued segments of the equity markets, such as healthcare, energy and technology that have significant potential for appreciation. Our experienced research team has extensive industry experience in the sectors they cover. They utilize a disciplined, bottom-up approach to identify promising investments, and the firm’s investment policies ensure liquidity horizons that are sufficient to take advantage of new opportunities. PAI is committed to providing exemplary client service, maintaining the highest level of ethics, operational excellence and professionalism. PAI is independently owned, and has been registered with the SEC since its inception in 1989

Details Hidden

Krensavage Asset Management (KAM) seeks superior absolute returns primarily through long term capital appreciation with a focus on capital preservation. The firm purchases securities they believe trade below their intrinsic value and selling securities they believes trade above their intrinsic value. KAM's investments focus on the purchase and sell of equity securities of public companies in the healthcare industry. The firm may also invest in other industries, asset classes and markets that are poised for superior performance.

Details Hidden

TSW uses a combination of fundamental and quantitative analysis as the basis for their investment processes. Their typical assignments involve a specific strategy, such as \"mid-cap value\" or \"core plus fixed income\" in which they use a variety of equity and/or fixed income processes to select securities that are designed to outperform a specific industry benchmark. In other instances, usually for high net-worth clients, the strategies may be combined in order to produce a \"balanced portfolio\" to meet a specific client asset allocation objective or industry benchmark. TSW's strategies include: Equity (Domestic and International), Strategic High Income, Fixed Income, Custom Balanced, and WPS (long/short equity).

Recent Transactions
Details Hidden

United Therapeutics Corp. purchases SteadyMed Ltd.

Details Hidden

Emergent BioSolutions, Inc. purchases Emergent Virology LLC from United Therapeutics Corp.

Details Hidden

United Therapeutics Corp. purchases Revivicor, Inc. from Astellas Venture Management LLC, Highmark Health Ventures LLC

Transaction Advisors
Legal Advisor

Advised onUnited Therapeutics Corp. purchases SteadyMed Ltd.

Accountant

Advised onUnited Therapeutics Corp. purchases Medicomp, Inc.

Underwriter

Advised onUnited Therapeutics Corp. issued Common Stock

Legal Advisor

Advised onUnited Therapeutics Corp. purchases SteadyMed Ltd.

Legal Advisor

Advised onUnited Therapeutics Corp. purchases SteadyMed Ltd.

Legal Advisor

Advised onUnited Therapeutics Corp. issued Common Stock

Advisors & Consultants
Senior Advisor

Former Director, President & Co-Chief Executive Officer at United Therapeutics Corp.

Legal Advisor

Partner at Simpson Thacher & Bartlett LLP

Clients

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Cigna is more than a health insurance company. They are a global health service company. Cigna works with employers and organizations around the world helping employees stay healthy and on the job. They work closely with brokers and consultants to develop innovative programs, help individuals and families improve their health, well-being and sense of security—and lower their medical costs. And, Cigna provides access to a global network of local physicians and hospitals—as well as 24/7/365 live customer service.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

Key Stats and Financials As of 2018
Market Capitalization
$4.02B
Total Enterprise Value
$3.64B
Earnings Per Share
$13.39
Revenue
$1.63B
Net Profit
$589M
EBITDA
$847M
EBITDAMargin
52.02%
Total Debt
$250M
Total Equity
$2.81B
Enterprise Value Sales
2.24x
Enterprise Value EBITDAOperating
4.3x
TEVNet Income
6.19x
Debt TEV
0.07x
Three Year Compounded Annual Growth Rate Of Revenue
3.56%
Five Year Compounded Annual Growth Rate Of Revenue
7.82%
Political Donations
Investments
Details Hidden

Respira Therapeutics, Inc. focuses on pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM.

Details Hidden

Celularity, Inc. operates as a biotechnology company that focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in warren, NJ.

Details Hidden

TAI Diagnostics, Inc. provides biotechnology services. It focuses on developing innovative diagnostic tests for monitoring the health of transplanted organs. The company was founded by Aoy Tomita-Mitchell and Michael E. Mitchell in 2015 and is headquartered in Wauwatosa, WI.

Suppliers
Eli Lilly & Company Hospitals & Patient Services | Indianapolis, Indiana

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Minnetronix Medical, Inc. Holding Companies | ST. PAUL, MN

Minnetronix Medical, Inc. provides design, development, manufacturing, commercialization services to the electronics-based medical device and life science marketplaces. The company was founded in 1996 and is headquartered in St. Paul, MN.

Baxter International, Inc. Pharmaceuticals | DEERFIELD, IL

Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2011 sales of $13.9 billion and has approximately 48,500 employees.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Allergan Plc Pharmaceuticals - Dublin, DU

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Middlesex

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Awards & Honors
Rank #12
2012
Forbes Magazine - 50 Best Small Companies 2012
Sponsored by Forbes Media LLC
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by United Therapeutics Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of United Therapeutics Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and United Therapeutics Corp..